A detailed history of Rothschild Investment LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Rothschild Investment LLC holds 40 shares of PRTA stock, worth $699. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40
Previous 10 300.0%
Holding current value
$699
Previous $206,000 224.76%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$16.73 - $24.79 $501 - $743
30 Added 300.0%
40 $669,000
Q2 2024

Jul 30, 2024

BUY
$19.54 - $26.15 $195 - $261
10 New
10 $206,000
Q1 2024

Jul 31, 2024

SELL
$24.75 - $40.66 $123 - $203
-5 Reduced 50.0%
5 $124,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $821M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.